Fig. 3

a HRR gene mutation prevalence in the Foundation Medicine dataset across six tumour types and b bi-allelic loss of function rates of HRR gene mutations in the Foundation Medicine dataset across six tumour types. To prevent multiple counting of a patient so that they are not over-estimated in samples that have a mutation in multiple genes only, one was chosen for representation based upon biological significance, for example, when BRCA is present, it will be called BRCA, even though an ATM is also detected